Menu Search
Equities

Neuraxis Inc

NRXS:ASQ

Neuraxis Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.60
  • Today's Change-0.33 / -11.26%
  • Shares traded28.63k
  • 1 Year change-26.14%
  • Beta--
Data delayed at least 15 minutes, as of Sep 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Neuraxis Inc's revenues fell -8.37% from 2.68m to 2.46m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 4.78m to a larger loss of 14.63m.
Gross margin87.29%
Net profit margin-672.94%
Operating margin-593.88%
Return on assets-731.17%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Neuraxis Inc fell by 175.14k. Cash Flow from Financing totalled 6.59m or 267.91% of revenues. In addition the company used 6.69m for operations while cash used for investing totalled 71.78k.
Cash flow per share-2.71
Price/Cash flow per share--
Book value per share-0.7686
Tangible book value per share-0.7836
More ▼

Balance sheet in USDView more

Neuraxis Inc uses little or no debt in its capital structure.
Current ratio0.2781
Quick ratio0.2724
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.